Mid-sized pharma companies having brands that are not in top-ten in their therapies are likely to face the most brunt if doctors are compelled to write only generic names in their prescriptions to the patients.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600